Speaker Details

Anthony Fernandez, MD, FAAD

Anthony Fernandez, MD, FAAD

SESSIONS

S004 Hot Topics
Mar 27, 2026 • 12:00 AM - 12:00 AM • Bluebird 1A
F097 Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Still a Bunch of Management Controversies
Mar 30, 2026 • 12:00 AM - 12:00 AM • Mile High 4A

DISCLOSURES

Amgen – Speaker(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); Biogen – Consultant(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Investigator(Grants/Research Funding); EMD Serono – Investigator(Grants/Research Funding); Galderma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Investigator(Grants/Research Funding); Johnson & Johnson – Advisory Board(Honoraria); Mallinckrodt Pharmaceuticals – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Merck & Co., Inc – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Priovant – Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(Honoraria); UCB – Consultant(Honoraria);